Women in England with breast cancer may qualify for drug that buys ‘precious’ time

Women in England with breast cancer may qualify for drug that buys ‘precious’ time Women with advanced breast cancer in England will be able to benefit from a new type of immunotherapy on the NHS after a U-turn by the medicines watchdog.

The National Institute for Health and Care Excellence (Nice) has overturned its draft rejection of Keytruda (pembrolizumab) and said women in England can take the drug in combination with chemotherapy. The Guardian

See also:

• New hope for women with advanced breast cancer as immunotherapy drug approved for NHS The Independent